2020, Number 04
Variability of the evolutionary PCR results in patients with COVID-19
Language: Spanish
References: 16
Page: 565-577
PDF size: 922.07 Kb.
ABSTRACT
Introduction: The new coronavirus specimen (COVID-19), has generated scenarios of sanitary emergencies in many countries from all continents.Objective: To characterize the variability of the PCR evolutionary results in patients with COVID-19.
Methods: An observational, descriptive, prospective and cross-sectional study was carried out in 68 patients with COVID-19 (children and adults from both sexes) admitted in Dr. Joaquín Castillo Duany Military Hospital in Santiago de Cuba, from March 12th to April 30th, 2020. To collect the virological, the nasal and pharyngeal use of isotope was carried out, which analysis of PCR-RT was processed in the territorial reference center. Management, social, demographic and epidemiological variables were included, among others.
Results: Female sex prevailed in the series (52.9 %). Two PCR-RT fast tests were made to all the patients, through their clinical course, 40.0 % of the children and 10.0 % of the aged patients requiered a third virological test. In the second and third third of the clinical and epidemiological observation period, the report of the result averaged 1.5 days (SD ± 0.6) and 3.2 days (SD±1.6), respectively. After 15 days of treatment there were active positive cases in all populational groups; likewise 60.0 % of those with viral charge between 16-20 days were asymptomatic, as the 66.7 % of those with more than 20 days under medication.
Conclusions: Independently from the age and duration of the medical treatment, some patients remained with detectable viral charge. It is not adviced to discharge patients without a negative PCR-RT, above all for asympthomatic cases, in whom the evolutionary clinical course has been less favorable.
REFERENCES
Fei Z, Ting Y, Ronghui D, Guohui F, Ying L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Rev The Lancet Infec Des. 2020 [citado 27/04/2020]; 395. Disponible en: en: https://www.sciencedirect.com/science/article/pii/S0140673620305663
Rojas Gambasica JA, Urriago GJD, Montaño Villalobos YC, Moreno AraqueL, Ahumada Bayuelo E. Enfoque y manejo clínico de pacientes con enfermedad por Sars Cov2 (Covid-19) en unidad de cuidado intensivo. Rev Med Sanitas. 2020 [citado 26/04/2020]; 23(1). Disponible en: https://www.unisanitas.edu.co/Revista/74/02Rev_Medica_Sanitas_23-1_JARojas_el_at.pdf
Ramírez Truque M, Herrera Morice M. Rol del laboratorio clínico ante la epidemia del COVID-19: revisión de los métodos diagnósticos disponibles y sus limitaciones. Rev Med Costa Rica. 2020 [citado 28/05/2020]; 85(629). Disponible en: http://www.revistamedicacr.com/index.php/rmcr/article/viewFile/295/272
Guzmán Del Giudice OE, Lucchesi Vásquez EP, Trelles De Belaúnde M, Pinedo Gonzales RH, Camere Torrealva MA, Daly A, et al. Características clínicas y epidemiológicas de 25 casos de COVID-19 atendidos en la Clínica Delgado de Lima. Rev Soc Peruana Med Inter. 2020 [citado 29/05/2020]; 23(1). Disponible en: https://doi.org/10.36393/spmi.v33i1.506
Fernández Lázaro D, Sanz Gómez N, Sánchez Serrano N, Alaoui Sosse A, Aldea Mansilla C. Estandarización de Emergencia para el Diagnóstico del virus SARS-CoV-2 mediante la reacción en cadena de la polimerasa de transcripción reversa en tiempo real (RT-PCR) en situación de pandemia de COVID-19. REMASP 2020 [citado 29/05/2020];4(7). Disponible en: http://remasp.es/article/view/2065
Madrigal Rojas JP, Quesada Loría M, García Sánchez M, Solano Chinchilla A. SARS CoV-2, manifestaciones clínicas y consideraciones en el abordaje diagnóstico de COVID-19. Rev Med Costa Rica. 2020 [citado 30/05/2020];85(629). Disponible en: http://www.revistamedicacr.com/index.php/rmcr/article/viewFile/287/264